PAUL MALLARI: Open Payments
NPI 1801889787 · JOHNSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,811 in 334 payments from 19 companies in 2025. Trend: 2023 $6,015 · 2024 $6,161 · 2025 $6,811
Food & beverage: $6,711Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 98 | $1,775 |
| Janssen Biotech, Inc. | 60 | $1,051 |
| Arcutis Biotherapeutics, Inc. | 23 | $648 |
| LEO Pharma Inc. | 24 | $567 |
| PFIZER INC. | 29 | $443 |
| UCB, Inc. | 19 | $440 |
| Novartis Pharmaceuticals Corporation | 22 | $435 |
| E.R. Squibb & Sons, L.L.C. | 12 | $258 |
| Galderma Laboratories, L.P. | 11 | $239 |
| Lilly USA, LLC | 10 | $223 |
Products named: SKYRIZI, TREMFYA, Zoryve, RINVOQ, ADBRY, Bimzelx, CIBINQO, DUPIXENT.
Industry payments across RI — which companies pay providers there.
